These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35925888)

  • 1. Heat-hypersensitive mutants of ryanodine receptor type 1 revealed by microscopic heating.
    Oyama K; Zeeb V; Yamazawa T; Kurebayashi N; Kobirumaki-Shimozawa F; Murayama T; Oyamada H; Noguchi S; Inoue T; Inoue YU; Nishino I; Harada Y; Fukuda N; Ishiwata S; Suzuki M
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2201286119. PubMed ID: 35925888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
    Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
    Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
    Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
    Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
    J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired interaction between skeletal ryanodine receptors in malignant hyperthermia.
    Liang X; Chen K; Fruen B; Hu J; Ma J; Hu X; Parness J
    Integr Biol (Camb); 2009 Sep; 1(8-9):533-9. PubMed ID: 20023768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol binds and inhibits skeletal muscle ryanodine receptor 1.
    Joseph TT; Bu W; Haji-Ghassemi O; Chen YS; Woll K; Allen PD; Brannigan G; van Petegem F; Eckenhoff RG
    Br J Anaesth; 2024 Nov; 133(5):1093-1100. PubMed ID: 39304470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2+ dynamics in primary skeletal myocytes.
    Tsuboi Y; Oyama K; Kobirumaki-Shimozawa F; Murayama T; Kurebayashi N; Tachibana T; Manome Y; Kikuchi E; Noguchi S; Inoue T; Inoue YU; Nishino I; Mori S; Ishida R; Kagechika H; Suzuki M; Fukuda N; Yamazawa T
    J Gen Physiol; 2022 Nov; 154(11):. PubMed ID: 36200983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia.
    Michelucci A; Paolini C; Boncompagni S; Canato M; Reggiani C; Protasi F
    FASEB J; 2017 Aug; 31(8):3649-3662. PubMed ID: 28465322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of novel type1 ryanodine receptor inhibitor on skeletal muscle diseases].
    Yamazawa T; Kobayashi T; Kurebayashi N; Murayama T
    Nihon Yakurigaku Zasshi; 2022; 157(1):15-22. PubMed ID: 34980804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.
    Andronache Z; Hamilton SL; Dirksen RT; Melzer W
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4531-6. PubMed ID: 19246389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
    Gomez AC; Holford TW; Yamaguchi N
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.
    Chelu MG; Goonasekera SA; Durham WJ; Tang W; Lueck JD; Riehl J; Pessah IN; Zhang P; Bhattacharjee MB; Dirksen RT; Hamilton SL
    FASEB J; 2006 Feb; 20(2):329-30. PubMed ID: 16284304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
    Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
    J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations.
    Yang T; Allen PD; Pessah IN; Lopez JR
    J Biol Chem; 2007 Dec; 282(52):37471-8. PubMed ID: 17942409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels.
    Bannister RA; Estève E; Eltit JM; Pessah IN; Allen PD; López JR; Beam KG
    J Gen Physiol; 2010 Jun; 135(6):629-40. PubMed ID: 20479108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Receptor Potential Cation Channels and Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia.
    Rafael Lopez J; Kaura V; Hopkins P; Liu X; Uryach A; Adams J; Allen PD
    Anesthesiology; 2020 Aug; 133(2):364-376. PubMed ID: 32665491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.